Curocell is a commercial-stage cell therapy company spanning from development to commercial manufacturing. Our mission is to transform cancer treatment by developing innovative, robust, and scalable cell therapy solutions that improve patient outcomes worldwide. We integrate scientific excellence with strategic business development to accelerate global access to life-saving immunotherapies. By leveraging our deep expertise in CAR-T CMC, we aim to develop collaborations with cell therapy companies that share the same mission. Our strong foundation in research and clinical studies enable us to bridge the gap between research, process optimization, and commercialization. We focus on enhancing manufacturing efficiency, regulatory compliance, and scalability to bring safe and effective treatments to market faster.